An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.
Bagalkot
Vaishali
V
Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryoung-dong, Buk-gu, Gwangju 500712, South Korea.
Farokhzad
Omid C
OC
Langer
Robert
R
Jon
Sangyong
S
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry; D052157:Aptamers, Nucleotide / Q000008:administration & dosage / Q000737:chemistry*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000378:metabolism; D018613:Microscopy, Confocal; D015394:Molecular Structure
D000970:Antineoplastic Agents; D052157:Aptamers, Nucleotide; D004317:Doxorubicin